No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D31
- Name in latin
- Neoplasma benignum oculi non specificatum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Eye, unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Eye, unspecified
- Benign neoplasm of eye and adnexa
- Benign neoplasm of eye and adnexa
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 154 | 100 | 54 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | 57.05 | 55.43 | 60.05 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 141
- Matched controls
- 1411
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D31.9
ICD-10 Finland
Benign neoplasm: Eye, unspecified
+∞
138.2
109
*
CBB30
NOMESCO Finland
Excision of lesion of eyelid
17.7
13.1
20
13
H02AB02
ATC
dexamethasone; systemic
27.7
11.4
15
6
2240A
ICD-9 Finland
Benign neoplasm of eye, Eyeball, except conjunctiva, cornea, retina and choroid
+∞
10.5
10
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
9.5
9
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
9.5
9
*
CBB99
NOMESCO Finland
Other excision or destruction of lesion of eyelid
39.4
9.2
11
*
115
Kela drug reimbursment
Breast cancer
+∞
8.4
8
*
2248X
ICD-9 Finland
Benign neoplasm of eye, Other specified parts of eye
+∞
8.4
8
*
130
Kela drug reimbursment
Malignant tumour
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
3401
FHL
Removal of local modification or taking a specimen in the operating room
+∞
7.3
7
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
+∞
7.3
7
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.4
7.2
38
138
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
5.8
6.9
19
37
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
42.1
6.8
8
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
6.3
6
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
6.3
6
*
CD2S4
NOMESCO Finland
Photography of eye
+∞
6.3
6
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
29
137
2.38
3.86
3.6
2.6
26.0
23.9
%
0.18
24
120
82
597
1.80
3.19
9.8
5.3
1.2
1.2
mmol/l
0.52
70
524
88
664
1.76
2.95
16.2
6.5
3.4
4.2
e9/l
4.03
82
577
56
378
1.76
2.72
6.1
2.0
2.3
2.4
mmol/l
1.43
48
319
6
10
6.19
2.72
1.5
1.2
—
—
—
0
0
6
10
6.19
2.72
1.5
1.2
—
—
—
0
0
8
21
3.96
2.50
1.5
1.8
—
—
—
0
0
23
119
2.10
2.46
2.1
1.9
1.3
1.5
%
0.83
18
105
6
13
4.75
2.29
1.5
1.2
—
—
—
0
0
8
24
3.46
2.21
1.4
1.5
—
—
—
0
0
6
15
4.12
2.06
2.0
1.9
—
—
—
0
0
28
166
1.84
2.05
2.1
1.8
—
—
—
0
0
8
26
3.19
2.04
1.4
1.2
—
—
—
0
0
67
505
1.58
2.02
4.0
3.8
62.4
40.0
ng/l
0.28
38
356
45
309
1.64
1.98
1.6
1.5
18.2
22.6
nmol/l
1.28
34
261
5
11
4.66
1.95
1.6
1.3
—
—
—
0
0
21
115
1.96
1.94
5.3
3.2
—
—
—
0
0
6
19
3.24
1.68
1.5
1.5
—
—
—
0
0
5
14
3.65
1.63
1.6
1.2
—
—
—
0
0
69
544
1.49
1.61
9.3
4.8
1.2
1.2
mmol/l
0.51
61
490
8
33
2.50
1.56
1.4
1.2
—
—
—
0
0
112
978
1.53
1.54
3.7
4.2
15.1
14.9
pmol/l
0.36
98
886
5
15
3.41
1.53
2.2
1.9
253.8
129.6
u/ml
—
5
9
7
28
2.57
1.47
2.1
1.3
—
—
—
0
0
6
24
2.56
1.31
1.8
1.8
15.7
12.0
u/ml
—
6
19
18
108
1.75
1.29
1.9
1.9
—
—
—
0
0
65
525
1.41
1.27
4.6
3.5
—
—
—
0
0
5
20
2.55
1.16
1.0
1.1
—
—
—
0
0
36
272
1.42
1.00
2.8
2.2
1.1
1.0
mg/l
0.26
28
210
17
110
1.61
0.95
2.0
1.9
—
—
—
0
0
105
950
1.33
0.87
5.2
4.1
16.3
11.7
mm/h
1.75
99
872
6
31
1.97
0.85
1.7
1.9
—
—
—
0
0
8
46
1.78
0.84
1.6
2.1
—
—
—
0
0
140
1334
1.54
0.78
22.1
13.7
84.0
76.2
umol/l
1.32
140
1334
12
75
1.65
0.77
1.9
1.4
—
—
—
0
0
62
530
1.28
0.76
2.3
2.0
89.2
94.7
pmol/l
0.37
33
264
9
54
1.71
0.76
4.7
1.2
—
—
—
0
0
10
60
1.71
0.74
16.2
4.0
23.8
24.7
mmol/l
—
10
54
133
1259
1.41
0.72
4.5
4.7
5.9
6.0
mmol/l
0.12
120
1139
126
1183
1.36
0.72
18.5
10.6
78.4
78.9
ml/min/173m2
0.09
111
954
121
1132
1.32
0.69
25.0
13.1
38.2
40.1
%
1.37
86
810
31
246
1.33
0.65
4.3
3.7
629.6
140.0
ng/l
0.44
25
193
5
30
1.69
0.62
1.2
1.2
—
—
—
0
0
31
248
1.31
0.62
2.0
1.7
1003.8
1129.8
nmol/l
0.22
20
193
17
123
1.43
0.61
11.5
3.3
1.9
2.4
mmol/l
0.24
11
97
80
720
1.23
0.60
6.5
3.8
6.8
6.6
mmol/l
0.28
75
663
59
516
1.23
0.57
2.2
2.3
80.3
77.7
nmol/l
0.31
51
450
23
178
1.34
0.57
3.2
2.7
0.8
0.7
ug/l
0.15
16
121
8
55
1.48
0.57
2.0
1.8
—
—
—
0
0
9
61
1.50
0.55
1.8
1.8
—
—
—
0
0
9
61
1.50
0.55
2.6
2.1
—
—
—
0
0
30
364
0.78
0.54
1.7
1.6
1.2
1.4
mmol/l
0.82
21
305
125
1188
1.28
0.53
4.7
4.9
1.8
1.9
mu/l
0.68
115
1080
31
254
1.28
0.52
4.4
3.7
21.5
24.8
%
0.41
15
122
55
485
1.21
0.49
10.0
3.6
34.4
35.7
g/l
0.95
50
455
82
751
1.20
0.48
3.4
3.0
—
—
—
0
0
11
153
0.70
0.48
8.9
7.3
—
—
—
0
0
7
47
1.51
0.48
1.0
1.5
—
—
—
0
0
14
106
1.35
0.41
3.5
5.3
440.0
256.7
ng/l
0.43
14
90
5
36
1.40
0.38
1.2
1.1
—
—
—
0
0
12
90
1.36
0.37
6.1
7.4
4.9
5.0
kpa
0.25
12
82
6
43
1.41
0.35
2.2
1.7
—
—
—
0
0
144
1407
1.36
0.35
31.1
17.8
130.8
135.7
g/l
3.56
144
1379
6
46
1.32
0.33
3.0
1.7
—
—
—
0
0
6
46
1.32
0.33
1.0
1.3
—
—
—
0
0
23
193
1.23
0.33
2.7
2.9
2.0
3.3
e6/l
0.45
13
106
37
326
1.18
0.33
3.5
2.3
356.8
7653.5
umol/l
1.74
31
279
24
206
1.20
0.28
2.6
2.6
0.7
1.3
e6/l
0.54
14
117
68
637
1.12
0.25
6.1
5.0
0.0
0.0
estimate
0.00
16
105
9
77
1.18
0.25
1.8
3.9
4.6
4.5
pmol/l
—
9
66
19
221
0.84
0.24
1.2
1.3
53.4
7.4
u/ml
—
6
72
67
631
1.11
0.22
4.2
3.7
0.0
0.0
estimate
0.00
16
109
8
103
0.76
0.22
1.5
1.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
1.0
—
0
7
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
7
61
1.15
0.18
6.1
2.1
1.1
1.3
%
—
7
61
14
162
0.85
0.17
5.8
4.8
31.6
32.8
%
—
8
103
31
336
0.90
0.15
4.6
3.8
0.0
0.0
estimate
0.00
15
102
28
256
1.11
0.15
3.9
2.1
—
—
—
0
0
123
1252
0.91
0.13
4.8
4.6
1.5
1.5
mmol/l
0.22
109
1152
67
644
1.07
0.13
4.3
3.7
0.0
0.0
estimate
0.00
16
102
86
835
1.07
0.12
3.7
2.8
48.9
43.2
u/l
0.26
77
788
46
439
1.07
0.10
3.5
2.9
—
—
—
0
0
12
106
1.14
0.10
3.1
1.7
—
—
—
0
0
5
46
1.09
0.09
2.0
1.5
—
—
—
0
0
22
237
0.92
0.09
1.1
1.3
18.8
36.8
iu/ml
1.19
12
75
127
1287
0.92
0.09
5.5
5.2
2.9
2.7
mmol/l
1.12
116
1189
7
68
1.03
0.08
1.4
1.3
—
—
—
0
0
6
70
0.85
0.08
1.0
1.0
—
—
—
0
0
36
345
1.06
0.06
3.5
2.8
0.2
0.3
e6/l
0.22
26
247
128
1267
1.06
0.06
20.9
11.7
20.4
21.8
mg/l
0.18
105
983
11
120
0.91
0.05
3.8
1.8
—
—
—
0
0
20
208
0.96
0.02
1.5
1.4
—
—
—
0
0
28
272
1.04
0.02
2.1
1.8
414.7
450.7
pmol/l
0.29
23
227
121
1202
1.03
0.02
6.4
6.0
40.3
39.9
mmol/mol
0.16
111
1120
125
1257
0.97
0.01
4.8
4.6
4.8
4.6
mmol/l
0.59
114
1167
121
1216
0.98
0.00
4.3
4.1
1.3
1.3
mmol/l
0.15
107
1109
22
219
1.01
0.00
1.4
1.4
—
—
—
0
0
50
496
1.01
0.00
4.6
3.7
—
—
—
0
0
12
123
0.97
0.00
9.0
4.2
0.6
1.4
mmol/l
—
7
95
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
9.3
—
0
6
0
6
0.00
0.00
0.0
1.2
—
3.3
—
0
6
0
7
0.00
0.00
0.0
1.1
—
13.4
—
0
7
0
5
0.00
0.00
0.0
1.2
—
0.3
—
0
5
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
71
0.99
0.00
1.6
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
220.1
—
0
8
0
8
0.00
0.00
0.0
1.0
—
9.5
—
0
8
29
290
1.00
0.00
1.2
1.2
7.2
2.4
u/ml
—
8
89
0
8
0.00
0.00
0.0
2.1
—
16.3
—
0
8
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: CD2_EYE_NOS_EXALLC – Benign neoplasm: Eye, unspecified
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).